v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Cash Flows [Abstract]    
Net loss $ (661,000) $ (761,000)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 101,000 158,000
Depreciation and amortization 72,000 74,000
Amortization of financing discounts 33,000 4,000
Changes in assets and liabilities    
Accounts receivable (323,000) (670,000)
Other receivables 77,000 (57,000)
Inventories (140,000) 372,000
Prepaid expenses and other assets (55,000) (66,000)
Accounts payable - trade (1,383,000) 222,000
Accrued expenses (103,000) 218,000
Net cash used in operating activities (2,382,000) (506,000)
Investing activities    
Purchase of property and equipment (646,000) (28,000)
Net cash used in investing activities (646,000) (28,000)
Financing activities    
Borrowings under line of credit 3,791,000 782,000
Repayment of line of credit (4,398,000) (1,402,000)
Issuance of convertible debt and warrants, net of $154,000 issuance cost 7,374,000
Repayment of mortgage note (2,170,000)
Financing agreement payments (70,000) (23,000)
Issuance of common stock, net of $26,000 issuance cost 2,974,000
Shares repurchased for income tax withholding under stock compensation program (160,000)
Net cash provided by financing activities 4,527,000 2,171,000
Net increase in cash 1,499,000 1,637,000
Cash, beginning of period 325,000 235,000
Cash, end of period 1,824,000 1,872,000
Cash paid for interest 185,000 19,000
Non-cash financing and investing activities:    
Conversion of notes payable to equity 420,000
Financed acquisition of long-term assets 95,000
Accounts payable arising from acquisition of long-term assets 15,000
Issuance of warrants to brokers in convertible debt and warrant offering $ 4,000